The reduced synapses, increased complement activation, enhanced microglial phagocytosis, and cognitive impairment were all alleviated in mice lacking C3, the C3a receptor, or with astrocyte-specific C3 gene deletion, compared to WT controls. This evidence concerns the gene C3 and Cognitive impairment.